SBIA
IRD

Sheaff Brock Investment Advisors’s Opus Genetics IRD Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-145
Closed -$25K – 697
2015
Q4 		$25K Buy
+145
New +$30.8K ﹤0.01% 639

Other funds holding IRD

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Sheaff Brock Investment Advisors's IRD Position: Q1 2016 in Review

Sheaff Brock Investment Advisors sold out of Opus Genetics (IRD) in Q1 2016, closing a stake of 145 shares — an estimated $25K sold.

Sheaff Brock Investment Advisors first reported a position in IRD in Q4 2015 and held it in 1 quarter. The position peaked at $25K in Q4 2015. 36 funds tracked by Wall St. Rank hold IRD as of Q1 2016.

  • Sheaff Brock Investment Advisors reported no remaining Opus Genetics position as of Q1 2016 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 145 Opus Genetics shares in Q1 2016, an estimated $25K.
  • Sheaff Brock Investment Advisors first reported a position in Opus Genetics in Q4 2015 and held it in 1 quarter.
  • Sheaff Brock Investment Advisors's Opus Genetics position peaked at $25K in Q4 2015.
  • 36 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2016.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2016, filed 25 Apr 2016.